Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


Quetiapine augmentation in treatment of panic disorder: A case report

Elif Onur.

Although most patients with panic disorder readily respond to serotonin reuptake inhibitors, some patients are treatment resistant to standard pharmacological treatments. Switching to another antidepressant, drug combination and augmentation strategies were
suggested to overcome the treatment resistance. There were few case reports in the literature adressing the usage of atypical antipsychotics in the treatment of resistant panic disorder patients. In the most of the cases, olanzapine were added to selective serotonin
reuptake inhibitors. There is no report on augmentation therapy with quetiapine in patients with panic disorder. In this report we presented a patient with panic disorder and agoraphobia who responded well to quetiapine added to ongoing paroxetine treatment.

Key words: Panic disorder, atypical antipsychotics, treatment, quetiapine

Share this Article

American Journal of Preventive Medicine and Public Health


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons